FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2761852945> ?p ?o ?g. }

• W2761852945 endingPage "594" @default.
• W2761852945 startingPage "585" @default.
• W2761852945 abstract "Utilization of fetal fibronectin testing and pregnancy outcomes among women with symptoms of preterm labor Sean C Blackwell,1 Erin M Sullivan,2 Allison A Petrilla,2 Xian Shen,2 Kathleen A Troeger,3 James D Byrne4 1Department of Obstetrics, Gynecology and Reproductive Sciences, University of Texas Health Sciences Center, Houston, TX, USA; 2Avalere Health, LLC, Health Economics and Outcomes Research, Washington, DC, USA; 3Hologic, Inc., Outcomes Research, Marlborough, MA, USA; 4Department of Obstetrics and Gynecology, Santa Clara Valley Medical Center, San Jose, CA, USA Objectives: To identify pregnant health plan members triaged through the emergency department (ED), including labor and delivery (ELD) units, with symptoms of preterm labor (PTL), and evaluate the use of fetal fibronectin (fFN) testing; and to calculate the rate of hospitalization and timing of delivery in relation to the ED visit. Methods: Retrospective cohort study using Medical Outcomes Research for Effectiveness and Economics Registry®, a national multipayer claims database. A cohort of pregnant women evaluated in an ELD with a diagnosis of PTL from June 2012 through November 2015 was identified. The proportion of women with PTL who received fFN testing was calculated.Results: A total of 23,062 patients met the criteria for inclusion in the study. The rate of fFN testing prior to delivery was 12.0%. Of the 23,062 patients included in the analysis, 75.9% were discharged home. Of those who were discharged from the emergency room, one in five went on to deliver within 3 days and almost 96% of this group was not screened for the presence of fFN. Of the remaining 24.1% of patients admitted to the hospital, 91.3% delivered during their stay. In a sensitivity analysis, the percentage of women who delivered within 3 days of the ELD encounter was lower for women who received fFN testing only (6.6%) versus those who had a history of transvaginal ultrasound (TVUS) only (21.6%). Furthermore, the rate of delivery within 3 days was lowest among patients who had both fFN testing and TVUS (4.7%).Conclusion: The utilization of fFN testing is 12%. The majority of pregnant patients triaged through the ELD with symptomatic PTL do not receive an fFN test. As part of PTL evaluation, fFN testing may identify women at increased risk for preterm delivery and help determine appropriate patient management. Keywords: preterm labor, pregnancy, emergency department, fetal fibronectin testing&nbsp" @default.
• W2761852945 created "2017-10-20" @default.
• W2761852945 creator A5027339105 @default.
• W2761852945 creator A5033714165 @default.
• W2761852945 creator A5062686747 @default.
• W2761852945 creator A5064524758 @default.
• W2761852945 creator A5074776548 @default.
• W2761852945 creator A5088498661 @default.
• W2761852945 date "2017-10-01" @default.
• W2761852945 modified "2023-10-16" @default.
• W2761852945 title "Utilization of fetal fibronectin testing and pregnancy outcomes among women with symptoms of preterm labor" @default.
• W2761852945 cites W15234352 @default.
• W2761852945 cites W1898998544 @default.
• W2761852945 cites W1991556657 @default.
• W2761852945 cites W2039767940 @default.
• W2761852945 cites W2052543696 @default.
• W2761852945 cites W2110330014 @default.
• W2761852945 cites W2114477597 @default.
• W2761852945 cites W2123127432 @default.
• W2761852945 cites W2135145601 @default.
• W2761852945 cites W2146355276 @default.
• W2761852945 cites W2149073690 @default.
• W2761852945 cites W2166516870 @default.
• W2761852945 cites W2167504804 @default.
• W2761852945 cites W2247309923 @default.
• W2761852945 cites W2263242704 @default.
• W2761852945 cites W2534264168 @default.
• W2761852945 cites W2558382987 @default.
• W2761852945 cites W2604431510 @default.
• W2761852945 cites W4234794804 @default.
• W2761852945 cites W4235060674 @default.
• W2761852945 doi "https://doi.org/10.2147/ceor.s141061" @default.
• W2761852945 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5633307" @default.
• W2761852945 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29042802" @default.
• W2761852945 hasPublicationYear "2017" @default.
• W2761852945 type Work @default.
• W2761852945 sameAs 2761852945 @default.
• W2761852945 citedByCount "8" @default.
• W2761852945 countsByYear W27618529452018 @default.
• W2761852945 countsByYear W27618529452020 @default.
• W2761852945 countsByYear W27618529452021 @default.
• W2761852945 countsByYear W27618529452022 @default.
• W2761852945 countsByYear W27618529452023 @default.
• W2761852945 crossrefType "journal-article" @default.
• W2761852945 hasAuthorship W2761852945A5027339105 @default.
• W2761852945 hasAuthorship W2761852945A5033714165 @default.
• W2761852945 hasAuthorship W2761852945A5062686747 @default.
• W2761852945 hasAuthorship W2761852945A5064524758 @default.
• W2761852945 hasAuthorship W2761852945A5074776548 @default.
• W2761852945 hasAuthorship W2761852945A5088498661 @default.
• W2761852945 hasBestOaLocation W27618529451 @default.
• W2761852945 hasConcept C10885799 @default.
• W2761852945 hasConcept C126322002 @default.
• W2761852945 hasConcept C131872663 @default.
• W2761852945 hasConcept C142724271 @default.
• W2761852945 hasConcept C201903717 @default.
• W2761852945 hasConcept C2777498106 @default.
• W2761852945 hasConcept C2779234561 @default.
• W2761852945 hasConcept C29456083 @default.
• W2761852945 hasConcept C3019152611 @default.
• W2761852945 hasConcept C46973012 @default.
• W2761852945 hasConcept C512399662 @default.
• W2761852945 hasConcept C54355233 @default.
• W2761852945 hasConcept C71924100 @default.
• W2761852945 hasConcept C72563966 @default.
• W2761852945 hasConcept C86803240 @default.
• W2761852945 hasConceptScore W2761852945C10885799 @default.
• W2761852945 hasConceptScore W2761852945C126322002 @default.
• W2761852945 hasConceptScore W2761852945C131872663 @default.
• W2761852945 hasConceptScore W2761852945C142724271 @default.
• W2761852945 hasConceptScore W2761852945C201903717 @default.
• W2761852945 hasConceptScore W2761852945C2777498106 @default.
• W2761852945 hasConceptScore W2761852945C2779234561 @default.
• W2761852945 hasConceptScore W2761852945C29456083 @default.
• W2761852945 hasConceptScore W2761852945C3019152611 @default.
• W2761852945 hasConceptScore W2761852945C46973012 @default.
• W2761852945 hasConceptScore W2761852945C512399662 @default.
• W2761852945 hasConceptScore W2761852945C54355233 @default.
• W2761852945 hasConceptScore W2761852945C71924100 @default.
• W2761852945 hasConceptScore W2761852945C72563966 @default.
• W2761852945 hasConceptScore W2761852945C86803240 @default.
• W2761852945 hasLocation W27618529451 @default.
• W2761852945 hasLocation W27618529452 @default.
• W2761852945 hasLocation W27618529453 @default.
• W2761852945 hasLocation W27618529454 @default.
• W2761852945 hasOpenAccess W2761852945 @default.
• W2761852945 hasPrimaryLocation W27618529451 @default.
• W2761852945 hasRelatedWork W1981713568 @default.
• W2761852945 hasRelatedWork W2052051211 @default.
• W2761852945 hasRelatedWork W2058476007 @default.
• W2761852945 hasRelatedWork W2061379485 @default.
• W2761852945 hasRelatedWork W2124576757 @default.
• W2761852945 hasRelatedWork W2347051845 @default.
• W2761852945 hasRelatedWork W2388787934 @default.
• W2761852945 hasRelatedWork W2418997351 @default.
• W2761852945 hasRelatedWork W4243768582 @default.
• W2761852945 hasRelatedWork W4299600072 @default.
• W2761852945 hasVolume "Volume 9" @default.

• next